Description
Certinib Capsules are targeted cancer therapy used to treat ALK-positive non-small cell lung cancer (NSCLC). By inhibiting ALK tyrosine kinase, they effectively block tumor growth and spread. These capsules offer a precise, potent option for advanced-stage cancer management, enhancing survival outcomes.